12 Biggest Mid-Day Gainers For Monday
- Medical Transcription Billing Corp (NASDAQ: MTBC) shares jumped 91.3 percent to $2.60. Medical Transcription Billing disclosed that it has developed Health Information Exchange interfaces between its clinical platforms and leading hospitals.
- China Commercial Credit Inc (NASDAQ: CCCR) shares climbed 17.7 percent to $2.46.
- China Rapid Finance Ltd – ADR (NYSE: XRF) shares gained 14 percent to $7.26.
- The Ensign Group, Inc. (NASDAQ: ENSG) shares climbed 13.2 percent to $20.32 after the company reported strong results for its first quarter.
- One Horizon Group Inc (NASDAQ: OHGI) shares surged 10.8 percent to $1.74.
- Costamare Inc (NASDAQ: CMRE) shares gained 8.5 percent to $7.31. Credit Suisse upgraded Costamare from Underperform to Neutral.
- Jumei International Holding Ltd(ADR) (NYSE: JMEI) shares gained 8.5 percent to $3.59 after dropping 13.12 percent on Friday.
- US Ecology Inc (NASDAQ: ECOL) shares climbed 7.5 percent to $50.70. Stifel Nicolaus upgraded US Ecology from Neutral to Buy.
- Alliance Holdings GP, L.P. (NASDAQ: AHGP) gained 5.7 percent to $28.18. Alliance Holdings reported Q4 earnings of $0.92 per share.
- Twitter Inc (NYSE: TWTR) rose 5.1 percent to $17.32after an encouraging report from the Wall Street Journal. According to the Wall Street Journal, Twitter has found a notable partner for a new 24–7 streaming news service: Bloomberg. The social media company's CEO Jack Dorsey is expected to provide further details of the new partnership on Monday at an event hosted by Bloomberg's founder, Michael Bloomberg.
- KMG Chemicals, Inc. (NYSE: KMG) gained 4.7 percent to $55.00. Gabelli & Co. upgraded KMG Chemicals from Hold to Buy.
- Schneider National Inc (NYSE: SNDR) shares rose 3.8 percent to $19.70. Bank of America initiated coverage of Schneider National with a Buy rating, while Credit Suisse initiated coverage on the stock with an Outperform rating.
Posted-In: Mid-Day GainersNews Intraday Update Markets Analyst Ratings Movers
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
